Sign Up to like & get
recommendations!
0
Published in 2019 at "Analytica chimica acta"
DOI: 10.1016/j.aca.2018.09.028
Abstract: Ranolazine (RZ) is an anti-anginal drug with a distinct mechanism of action and widely employed in patients with chronic angina. Its measurement is essential in clinical environment to ensure adequate drug level and understand the…
read more here.
Keywords:
anginal drug;
anti anginal;
graphene;
drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2018.12.008
Abstract: BACKGROUND The cornerstone of the treatment of patients affected by stable angina is based on drugs administration classified as first (beta-blockers, calcium channel blockers, short acting nitrates) or second line treatment (long-acting nitrates, ivabradine, nicorandil,…
read more here.
Keywords:
anti anginal;
systematic review;
review;
drugs systematic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)33435-6
Abstract: Background: Beta blockers, calcium channel blockers and nitrates are commonly used to manage patients with stable angina. Despite available treatment options, there is yet to be a single preferred agent. The objective of this meta-analysis…
read more here.
Keywords:
stable angina;
anti anginal;
treatment;
meta analysis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of cardiovascular pharmacology"
DOI: 10.1097/fjc.0000000000001436
Abstract: ABSTRACT Angina pectoris remains a significant burden despite advances in medical therapy and coronary revascularization. Many patients (up to 30%) with angina have normal coronary arteries, with coronary microvascular disease (CMD) and/or coronary artery vasospasm…
read more here.
Keywords:
cardioprotective anti;
review;
efficacy;
anginal efficacy ... See more keywords